Retained products of conception: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{SI}} {{CMG}} ==Overview== Retained products of conception complicate nearly 1% of all pregnancies. It occurs with greater frequency after termination of pregnancy ...") |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Retained products of conception complicate nearly 1% of all pregnancies. It occurs with greater frequency after termination of pregnancy than after vaginal or cesarean delivery. | Retained products of conception complicate nearly 1% of all pregnancies. It occurs with greater frequency after termination of pregnancy than after vaginal or cesarean delivery. | ||
==Differentiating | ==Differentiating Retained products of conception from other diseases== | ||
* Differentiation of these entities is important because retained products of conception is treated conservatively or with curettage while gestational trophoblastic disease may require chemotherapy. | * Differentiation of these entities is important because retained products of conception is treated conservatively or with curettage while gestational trophoblastic disease may require chemotherapy. | ||
*ß-human chorionic gonadotropin remains elevated in patients with gestational trophoblastic disease but falls to an undetectable level over 2–3 weeks in patients with retained products of conception. | *ß-human chorionic gonadotropin remains elevated in patients with gestational trophoblastic disease but falls to an undetectable level over 2–3 weeks in patients with retained products of conception. | ||
==Diagnosis== | ==Diagnosis== | ||
* Common symptoms include vaginal bleeding and abdominal or pelvic pain, similar to patients with [[ gestational trophoblastic disease]]. | * Common symptoms include vaginal bleeding and abdominal or pelvic pain, similar to patients with [[ gestational trophoblastic disease]]. | ||
| Line 24: | Line 25: | ||
Image: | Image: | ||
Retained products of conception CT 004.jpg | |||
Image: | |||
Retained products of conception CT 005.jpg | |||
</gallery> | |||
'''Patient #1: MR images demonstrate retained placental tissue''' | |||
<gallery> | |||
Image: | Image: | ||
Retained placenta 001.jpg | |||
Image: | |||
Retained placenta 002.jpg | |||
Image: | |||
Retained placenta 003.jpg | |||
Image: | |||
Retained placenta 004.jpg | |||
</gallery> | </gallery> | ||
Latest revision as of 15:22, 1 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Retained products of conception complicate nearly 1% of all pregnancies. It occurs with greater frequency after termination of pregnancy than after vaginal or cesarean delivery.
Differentiating Retained products of conception from other diseases
- Differentiation of these entities is important because retained products of conception is treated conservatively or with curettage while gestational trophoblastic disease may require chemotherapy.
- ß-human chorionic gonadotropin remains elevated in patients with gestational trophoblastic disease but falls to an undetectable level over 2–3 weeks in patients with retained products of conception.
Diagnosis
- Common symptoms include vaginal bleeding and abdominal or pelvic pain, similar to patients with gestational trophoblastic disease.
Patient #1: US and CT images demonstrate retained products of conception
Patient #1: MR images demonstrate retained placental tissue
